Windmills in the water off of coast of Belgium and Netherlands
Windmills in the water off of coast of Belgium and Netherlands

© Norther wind farm off the coast of Belgium and the Netherlands provides renewable energy for our operations in both countries.

Environmental Health
Environmental Health
  • 302-1
    Energy consumption within the organization
  • 302-2
    Energy consumption outside of the organization
  • 302-3
    Energy intensity
  • 302-4
    Reduction of energy consumption
  • 305-1
    Direct (Scope 1) GHG emissions
  • 305-2
    Energy indirect (Scope 2) GHG emissions
  • 305-3
    Other indirect (Scope 3) GHG emissions
  • 305-4
    GHG emissions intensity
  • 305-5
    Reduction of GHG emissions
  • 305-6
    Emissions of ozone-depleting substances (ODS)
  • 305-7
    Nitrogen oxides (NOX), sulfur oxides (SOX), and other significant air emissions

Becoming more energy- and carbon-efficient are essential ways we can reduce our impact on the planet while maintaining cost- effective manufacturing and supply for our patients, consumers and customers around the world. We have a long history of innovation and leadership in energy management, and have taken sustained, long-term action to reduce our greenhouse gas (GHG) emissions.

CDP’s Climate  Security A List Award
For the second consecutive year, we were named to the CDP Climate Change A List, putting us among the top 2% of companies participating in the survey.  

Clean energy: In 2019, we became founding members with Board representation of the Renewable Energy Buyers Alliance (REBA), an association for large-scale energy buyers working toward the creation of a resilient, zero-carbon energy system across the United States. We have collaborated heavily with non-governmental organizations and peer companies in the REBA membership, which has helped us progress our renewable energy initiatives.

Through REBA, we can help make renewable energy more accessible, not just for Johnson & Johnson, but for our entire value chain. By taking a multi-pronged approach to removing barriers for renewable energy adoption, we hope to drive the impact well beyond our operations.
Jed Richardson Senior Director, Environmental Stewardship, Johnson & Johnson
Driving climate action in C40 Cities
We continue to make progress on our partnership with 30 C40 Cities committing to drive progress on climate actions that also have air quality improvements and health co-benefits.

An analysis conducted by C40 of climate actions taken in 25 cities focused on cleaner transport, industry and energy, and more efficient buildings, showed that carbon emissions could be significantly reduced while at the same time improving air quality for the citizens in these cities. Considering that air pollution is responsible for an estimated 25% of all adult deaths from heart disease and stroke, 43% from chronic obstructive pulmonary disease and 29% from lung cancer,16 these actions in turn could help prevent thousands of premature deaths and hospital admissions due to air pollution. The C40 partnership continues to expand to more cities, driving the business case for additional climate and clean air actions across all cities in the program.
CO2 emissions decreased by 32% globally since 2010 (Scope 1 and Scope 2).
30% of our electricity is produced or procured from renewable energy sources.

Energy & emissions

We continue to advance energy efficiency and GHG emission- reduction initiatives across our global manufacturing operations and supply chain, using ISO 50001 as a guide in our energy management strategy. Examples of our climate initiatives in 2019 include:

LEED certification in Ireland: The Janssen Sciences Ireland campus in Cork, dedicated to biologics manufacturing and testing, achieved LEED (Leadership in Energy & Environmental Design) silver certification. LEED green building features at Cork include: charging stations for up to 22 electric cars, covered bicycle parking, open space for protecting natural vegetation, adjustable sun-shades on each building level that reduce solar glare and heat gain within the building, and two wind turbines that provide renewable electricity for approximately 50% of the site’s electricity usage each year.

A book with an i to represent highlight
Green buildings are healthy for the environment and for all those who work in them. Our goal is LEED certification for all new Johnson & Johnson buildings and renovations of $5 million or more. In 2019, eight million square feet—or 13% of all our built space—was LEED-certified.

Wind energy in four countries: In 2019, we accelerated our renewable energy efforts with four new power purchase agreements in Belgium, Ireland, Mexico and the Netherlands totaling over 370,000 megawatt-hours (MWh) per year, significantly advancing progress toward our 100% renewable electricity goal.

We also installed a windmill at our largest chemical production site in Geel, Belgium. The windmill has a capacity of 3.4 MW of electricity production and is expected to provide up to 15% of Geel’s electricity consumption.

Geothermal energy at our site in Beerse, Belgium: Janssen’s Beerse campus is the largest energy user of all Johnson & Johnson sites worldwide, and in 2019 we commenced drilling of two geothermal energy wells, each around 2.4 kilometers (1.5 miles) deep, that will bring hot water up from the ground. When completed, this renewably sourced hot water will substantially reduce the site’s energy needs and CO2 emissions.

We anticipate that using geothermal energy will reduce our CO2 emissions in Beerse by about 30%. This equals the emissions generated by about 3,000 households.
Marijke Anthuenis Director, Project Management, Janssen Pharmaceutical Companies of Johnson & Johnson
doughnut chart displaying on site clean energy capacity

Optimizing cooling systems in Puerto Rico: We succeeded in reducing our CO2 emissions by more than 1,300 tons annually at our plant in Las Piedras, Puerto Rico, through optimizing a chilled water system in the plant, including replacement of two chillers and three cooling towers with more energy-efficient technology.

Improving energy efficiency in cleanrooms in the Netherlands: Janssen Vaccines & Prevention B.V., in Leiden, the Netherlands, achieved approximately 10% energy reduction through reducing the airflow of cleanrooms after work hours while maintaining quality and biosafety requirements. As air handling units account for about 50% of energy use in our cleanrooms, this positively impacted our overall energy consumption and resulting GHG emission levels.

Capital expenditure for energy efficiency: Energy efficiency programs at our most energy-intensive manufacturing and R&D sites remain a priority, and are allocated up to $40 million per year in capital relief for energy projects through our CO2 Capital Relief Program. To be eligible for funding, projects must demonstrate potential CO2 savings and should provide a financial return of 15% or higher.

Task Force on Climate-related Financial Disclosures (TCFD): We support the TCFD recommendations for climate-related disclosures. See our annual CDP Climate Report for additional climate-related disclosures based on TCFD recommendations.

CO2 Capital Relief Program Overview (2005 – 2019)
  • 266
    projects approved
  • 231
    projects completed
  • $431 million
    total spend on completed projects
  • $80 million
    annual energy cost savings*
  • 2,247
    TJ annual energy savings*
  • 287,931
    MT CO2 annual GHG emissions avoided*
    *Results from completed projects. Based on fuel and electricity reduction calculations. Avoidance of energy consumption and GHG emissions calculated by comparing energy consumption before project implementation and expected consumption after implementation using engineering estimates at the time the projects are approved.

Our Performance

Energy Use1




Total energy use (TJ) 12,702 13,208 12,685
From renewable sources 2,118 2,246 1,816
From non-renewable sources 10,584 10,962 10,869
Energy intensity ratio (TJ/$billion USD)2 155 162 164
Percentage change in energy intensity compared to 2010 baseline (TJ/$billion USD)2 (29%) (24%) (24%)

Purchased Energy Use by Type (TJ)1




Electricity 6,421 6,583 6,352
Natural gas 4,808 5,020 4,892
Diesel 465 592 929
Direct heating/cooling 274 180 238
Propane 51 90 64
Biogas 26 28 23
Fuel Oil 15 15 15
Total purchased energy 12,059 12,507 12,512

On-Site Generated Energy Use by Type (TJ)1




Co-generation 439 525 581
Wind 97 78 65
Solar PV 78 56 82
Geothermal 6 18 24
Fuel cell 22 23 24
Biomass 2 2 2
Total on-site generated energy 643 701 778

Greenhouse Gas (GHG) Emissions3




Scope 1 GHG emissions, total (MT CO2e)4 415,094 452,407 474,497
Scope 1 GHG emissions, by source (MT CO2e)4
Facilities1 278,717 308,200 329,731
Sales fleet15 114,681 122,194 123,179
Refrigerants16 12,979 12,298 9,830
Aviation 8,717 9,715 11,757
Scope 2 GHG emissions, facilities (MT CO2e)1, 4
Location-based 648,598 681,416 685,819
Market-based5 518,542 583,361 639,323
Scope 3 GHG emissions, by source (MT CO2e)4, 14
Purchased goods and services6 9,229,943 8,826,462 8,117,919
Upstream transportation and distribution6 2,201,590 2,039,872 1,893,440
Business travel6, 7 601,637 768,392 695,306
Employee commuting8 267,881 351,260 348,400
Capital goods6 281,092 271,442 246,076
Fuel- and energy-related activities9 47,245 50,821 46,524
Upstream leased assets10 39,830 39,981 45,702
Waste generated in operations11 3,618 3,702 3,812
Downstream product transportation12 Available 12/2020 65,447 45,850
Use of sold products13
Direct 168,612 78,051 73,503
Indirect 7,248,612 6,894,347 6,260,427
End of life treatment of sold products13 209,994 222,404 211,531
GHG emissions intensity ratio (Scope 1 and Scope 2) per revenue (MT CO2e/million USD) 11 13 15
Percentage decrease in GHG emissions intensity
(Scope 1 and Scope 2) per revenue compared to 2010 baseline (MT CO2e /million USD)
49% 43% 34%

Air Emissions by Category




Hazardous air pollutant (HAP) emissions (MT) 39.98 30.25 50.14
Volatile organic compound (VOC) emissions (MT) 394.07 414.05 607.99
Particulate matter (PM) emissions (MT) 116.56 247.14 205.22
Refrigerant emissions (MT) 8.01 7.85 6.12
Ozone depleting substances emissions (MT) 1.11 1.53 2.35
Sulfur oxide (SOx) emissions (MT) 51 64 99
Mono-nitrogen oxides (NOx) emissions (MT) 254 288 290
Independent assurance statements by ERM CVS.

1 Includes site-specific data from all Johnson & Johnson-owned and -leased sites over 50,000 square feet where Johnson & Johnson has operational control, as well as manufacturing and R&D sites under 50,000 square feet, unless otherwise noted.

2 Our diverse product portfolio makes it difficult to track an organization-specific metric, therefore we use revenue as denominator for energy intensity. Energy intensity ratio includes electricity, stationary fuels, and district heating and cooling.

3 Selected year 2019 global GHG emissions inventory including Scope 1, Scope 2 (location- and market-based) emissions, Scope 3 emission categories 1, 2, 3, 4, 5, 6, 8, 9, the percentage of electricity use generated by renewable energy sources, and NOx and SOx emissions (from combustion sources) were third-party assured by ERM Certification and Verification Services Inc. Please refer to Independent Assurance Statement for GHG Emissions Data in this Report.

4 In accordance with guidance from World Resources Institute Corporate Accounting and Reporting Standard, we restated the 2017-2018 values to reflect newly released electricity grid emission factors as well as addition or removal of acquisitions and divestitures. This threshold for restatement deviates from the one included in the About this Report section. We do not currently use purchases, sales or transfers of offsets in our GHG accounting. Gases covered in these calculations include CO2, CH4, N2O, and HFCs. Perfluorinated chemicals, sulfur hexafluoride and nitrogen trifluoride do not result from our operations. We do not calculate or report biogenic CO2 emissions in MT CO2e separately from the gross direct (Scope 1) GHG emissions. Electricity emission factors are obtained from the International Energy Agency’s CO2 Emissions from Fuel Combustion Report and the U.S. Environmental Protection Agency's eGRID publication for location-based Scope 2 reporting, and from supply contracts and residual emission factors, where available, for market-based Scope 2 reporting. Fuel emission factors are obtained from the EPA Climate Leaders publication. Global Warming Potentials are obtained from the Intergovernmental Panel on Climate Change Fifth Assessment Report. The chosen consolidation approach for emissions is operational control.

5 We did not report Scope 2 emissions using the market-based method prior to 2017. Starting from 2017, we are reporting Scope 2 emissions using both location-based and market-based methods, based on the latest Scope 2 guidance from the World Resources Institute in the Corporate Accounting and Reporting Standard.

6 Emissions were calculated using Company spend in the reporting year paired with appropriate economic input/output (IO) emission factors from Carnegie Mellon’s 2002 dataset. Where more specific primary data were able to be obtained, they were used in place of the IO calculation methodology.

7 Business Travel emissions for reporting year 2017 and 2018 are being restated because of the reclassification of spend into updated categories.

8 Emissions from Employee Commuting were calculated using survey data from a sample of employees in all regions and extrapolated for all global employees. It should be noted that because of the assumptions that were made, Johnson & Johnson did not receive third-party limited assurance for this scope, but will work to improve these assumptions in the coming years.

9 Emissions from Fuel-and Energy-related Activities were calculated for emissions from transportation and distribution losses from purchased electricity. Emissions were calculated by combining purchased electricity with an appropriate emissions factor and percentage grid loss for each location.

10 Emissions from Upstream Leased Assets were calculated by applying the energy intensity from office locations in our Scope 1 and Scope 2 footprint to the building area of leased assets less than 50,000 SqFt, which are excluded from Scope 1 and Scope 2 reporting.

11 Emissions from Waste Generated in Operations were calculated for non-hazardous waste from manufacturing and R&D operations using DEFRA's emissions factors for waste. Emissions for 2017-2018 are being restated because of an update in calculation methodology.

12 Emissions from Downstream Transportation and Distribution were calculated using the U.S. EPA’s SmartWay Program, and are provided for U.S. shippers only.

13 Emissions from the Use of Sold Products and the End-of-Life Treatment of Sold Products were calculated using sales volumes for all Johnson & Johnson products combined with lifecycle assessment (LCA) models where sales volumes could be obtained; where they could not be obtained, sales revenues and average unit prices were used to estimate volumes. Because of the size of our product portfolio, LCAs were not performed for every Johnson & Johnson product, so products were placed into LCA categories and a representative product LCA was applied. It should be noted that because of the assumptions that were made, Johnson & Johnson did not receive third-party limited assurance for these scopes, but will work to improve these assumptions in the coming years.

14 Emissions from the Processing of Sold Products, Downstream Leased Assets, Franchises, and Investments are not applicable to Johnson & Johnson operations.

15 Greenhouse gases covered in these calculations include CO2 only.

16 Includes site-specific data from all Johnson & Johnson manufacturing and R&D sites only.

You are leaving and entering a third-party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties.